Cargando…
Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer: A critical review
BACKGROUND: androgen receptor variant 7 (AR-V7) has been suggested as potential marker for treatment selection in men with metastatic castration-resistant prostate cancer (mCRPC). The aim of the present review is to critically analyze: frequency of the AR-V7 expression in mCRPC cases—impact of AR-V7...
Autores principales: | Sciarra, Alessandro, Gentilucci, Alessandro, Silvestri, Ida, Salciccia, Stefano, Cattarino, Susanna, Scarpa, Susanna, Gatto, Antonio, Frantellizzi, Viviana, Von Heland, Magnus, Ricciuti, Gian Piero, Del Giudice, Francesco, Maggi, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531263/ https://www.ncbi.nlm.nih.gov/pubmed/31083254 http://dx.doi.org/10.1097/MD.0000000000015608 |
Ejemplares similares
-
Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
por: Sciarra, Alessandro, et al.
Publicado: (2016) -
Laparoscopic versus open radical prostatectomy in high prostate volume cases: impact on oncological and functional results
por: Alessandro, Sciarra, et al.
Publicado: (2016) -
Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma
por: Silvestri, Ida, et al.
Publicado: (2013) -
A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer
por: Sciarra, Alessandro, et al.
Publicado: (2016) -
Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone
por: Salciccia, Stefano, et al.
Publicado: (2020)